PRA Wins Multiple 2020 CRO Leadership Awards

PRA recently took home multiple 2020 CRO Leadership Awards, competing in a crowded field of Contract Research Organizations (CROs) for the honors. Industry publication Life Science Leader and Clinical Leader, an online resource for clinical research, team up with Industry Standard Research (ISR) to determine each year’s award recipients.

Sixty CROs were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey during the 2020 competition. The organizations honored with awards proved themselves to be the top performers in the categories of Compatibility, Capabilities, Expertise, Quality, Reliability, and Phase IV.

PRA received 2020 CRO Leadership Awards in the following categories:

• Capabilities (Overall, Big Pharma)
  • Criteria:
    • All facilities fully owned
    • Complementary core competencies to in-house or other manufacturing contractors
    • Facility has the most up-to-date manufacturing technologies
    • Offers innovative solutions
    • Provides regulatory support for filing
    • Stability testing capabilities; storage capabilities
• Compatibility (Big Pharma)
  • Criteria:
    • Access to desired markets
    • Accessible senior management
    • Cultural fit
    • Financial strength/stability
    • Timely project communications
    • Well-regarded within the industry
• Expertise (Big Pharma)
  • Criteria
    • Ability to smoothly scale up manufacturing and transfer technology
    • Experienced level of staff
    • Offers innovative solutions
    • Provides regulatory support for filing
    • Scientific knowledge
    • Strong regulatory track record
• Phase IV (Overall, Big Pharma)
  • Criteria:
    • Right first-time measurements
    • Strong regulatory track record
    • Track record for meeting quality performance metrics
    • Up-front contingency planning, risk management
• Quality (Big Pharma)
  • Criteria:
    • All facilities fully owned
    • Financial strength/stability
    • Flexibility to adjust schedule for special requests
    • Has capacity to meet demands
    • Reliable on-time delivery
    • Timely project management

• Reliability (Overall, Big Pharma)
  • Criteria
    • Preformulation/formulation support
    • Process development and optimization
    • Analytical services, including stability and storage testing
    • Regulatory support

The awards are a reflection of PRA’s ability to quickly respond to clients’ needs and to support their diverse portfolios of work through our global experience, knowledge, and expertise.

Survey participants were recruited from pharma and biopharma companies of all sizes and screened for decision-making influence related to working with CROs. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.

PRA is honored to be the recipient of the 2020 CRO Leadership Awards. These accolades highlight the incredible talent of our hard-working team of employees around the globe. We’re enormously proud of the life-saving work we perform on behalf of our clients, and are equally proud our clients value the partnerships we’ve developed and the world-class services they receive.